ABSTRACT -Background -The diagnosis of inflammatory bowel disease is often delayed because of the lack of an ability to recognize its major clinical manifestations. Objective -Our study aimed to describe the onset of clinical manifestations in inflammatory bowel disease patients. Methods -A cross-sectional study. Investigators obtained data from interviews and the medical records of inflammatory bowel disease patients from a reference centre located in Brazil. Results -A total of 306 patients were included. The mean time between onset of symptoms and diagnosis was 28 months for Crohn's disease and 19 months for ulcerative colitis. The main clinical manifestations in Crohn's disease patients were weight loss, abdominal pain, diarrhoea and asthenia.
INTRODUCTION
Inflammatory bowel disease (IBD) is characterized by chronic inflammation of the gastrointestinal tract that may present pleomorphic clinical manifestations. The most common forms are ulcerative colitis (UC) and Crohn's disease (CD) (1, 2) . CD may affect the entire digestive tract from the mouth to the perianal region; its inflammatory process is characterized by discontinuous and segmental injuries that affect all layers of the intestine (transmural inflammation) (3) . The location is closely related to the clinical manifestation (4, 5) . The symptoms of CD are heterogeneous but generally include abdominal pain, weight loss and chronic diarrhoea (1, 4, 6) .
UC is characterized by diffuse inflammation of the colon restricted to the mucosa that usually affects the rectum and presents a proximal extension in a symmetrical and continuous pattern (1, 3, 7) . Symptoms depend on the extent and severity of the disease and more commonly include bloody diarrhoea, rectal bleeding and/or rectal urgency, but these patients also describe faecal incontinence, tenesmus and abdominal pain. Systemic symptoms of malaise, anorexia, fever or even nausea and vomiting may be present mainly during a severe attack (6) (7) (8) (9) .
The onset of clinical manifestations in inflammatory bowel disease patients
IBD can lead to disability and can have a significant impact on quality of life, with significant mental health problems, including depression. Moreover, patients develop professional and social constraints that interfere with work and recreational activities and result in decreased sexual satisfaction compared to the general population (6, (10) (11) (12) . The incidence of IBD is highest in the United States, the United Kingdom and Scandinavia (13) . Moreover, studies from IBD centres in Brazil report a clear increase in the prevalence of IBD in recent years (14, 15) . Despite this rise, IBD is still a relatively unknown disease, and its diagnosis is often delayed (13) . Our study aimed to describe the onset of clinical manifestations presented by these patients.
METHODS
This was a cross-sectional and observational study. The data were collected in the reference centre for inflammatory bowel disease at Hospital Geral Roberto Santos, Bahia, Brazil. The study was conducted between April 2015 and July 2016. The sample included patients from the outpatient unit. This study included consecutive IBD patients (≥18 year of age). Patients were interviewed about clinical manifestations. Information about the Montreal classification was The patients were classified according to the Montreal classification, but 21 (6.7%) IBD patients could not be classified (TABLE 2) .
The mean time from the onset of clinical symptoms to the diagnosis of CD was 37 months for patients with ileocolonic location, 26 months for patients with ileum location and 18 months for patients with colon location. In UC patients, the mean time from the onset of symptoms to diagnosis was 52 months for proctitis, 12 months for left-sided colitis and 12 months for extensive colitis. The majority of patients in our study had UC (54%), following the trend of other Brazilian studies (14) (15) (16) (17) and studies from other countries in Latin America (18) (19) (20) , the USA (21, 22) , Asia (83.2% UC) (23) , France (64% UC) (24) and Denmark (54% UC) (25) . One study from North America demonstrated that UC is more common in the Hispanic population (26) . Several studies in the world have shown that even though UC is still the most prevalent IBD in some places, CD has been the most incident IBD (27, 28) . In places with a higher incidence of IBD, the number of CD patients already surpasses that of UC patients (27, 29) . In our study, we noticed a small difference in the numbers of CD and UC patients.
The two diseases were more prevalent among females, following the trend in other countries (19, 24, 26, 29, 30) . The mean age at diagnosis in our study was 37 years. This finding follows results from Rio de Janeiro for both IBDs (36.7 years) (15) , as well as results from São Paulo (35-36 years) (17) and other countries such as Colombia (37.3 years), the Netherlands (34 years) (18) and Asia (36.3 years) (24) . Our data confirmed a trend showing a younger mean age at diagnosis for CD than for UC. This finding is probably explained by the tendency of CD to affect patients at a younger age (23, 31) . The mean time between the onset of symptoms and diagnosis was 23 months. This time was longer in CD patients (28 months) than in UC patients, which aligned with findings from previous studies (2, 14, 32, 33) . This timing reflects a noticeably delayed diagnosis compared to countries such as Peru (14.6 months) (18) , Iran (15.8 months) (30) and other international centres, in which the time between the onset of symptoms and diagnosis is 1 to 9 months (3, 25, 31, 34, 35) . The greater delay in the diagnosis of CD in relation to UC may be due to the lower frequency of alarming symptoms and a higher frequency of unspecific and insidious systemic symptoms, which, in some cases, may be confused with other aetiologies such as irritable bowel syndrome (IBS). Researchers have suggested that characteristics that are similar between irritable bowel syndrome and IBD have been associated with a delay in the diagnosis of Crohn's disease (36, 37) . The main clinical manifestation was weight loss, followed by diarrhoea, abdominal pain, faecal urgency, asthenia and blood in the stool. These findings are similar to results from the USA (34) . The description of fever during the onset of symptoms occurred in 38.3% of IBD patients. The extraintestinal manifestations at the beginning of the symptoms corresponded to reports from 41.6% of patients, slightly higher than findings presented in a study from Iran, in which 32.4% of IBD patients presented at least one extraintestinal manifestation at diagnosis (30, 38) . The CD patients presented more weight loss, abdominal pain, asthenia, appetite loss, malnutrition, anaemia, insomnia, fever, nausea and vomiting than UC patients. The UC patients reported more blood and mucus in the stool, urgency, faecal incontinence and tenesmus. More recently, a study suggested that dyssynergic defecation is highly prevalent in IBD patients (39) . The most common symptom described in CD patients was chronic diarrhoea (40) . Abdominal pain and weight loss were seen prior to diagnosis in 80 and 60% of the Caucasian patients, respectively (32, 41) . A Chinese study showed that the main manifestations of CD were non-specific symptoms such as abdominal pain (83.3%), diarrhoea (46.2%), weight loss (45.4%) and fever (37.1%) (42) . These results were similar to the Caucasian population and our sample, except for diarrhoea that presented a less frequency in the Chinese population. The most common symptom in our sample was weight loss, affecting 90% of the patients. This finding could be explained by the delay in the diagnosis. The extraintestinal involvement was quite relevant in CD patients, being far higher than that reported by the ECCO (European Crohn's and Colitis Organization) consensus (38) . It was noteworthy that systemic manifestations such as weight loss and asthenia showed a higher frequency than some other digestive symptoms associated with IBD.
The main clinical manifestations in UC patients observed in our study were stool blood, diarrhoea, faeces mucus, weight loss, abdominal pain and asthenia. Data from developed countries, Asian Centers and from our study are similar about the main symptoms at the onset of the clinical manifestation (42) . As reported by the second ECCO guideline for ulcerative colitis, the main symptom of UC is visible blood in the stool (7) . Our finding is in agreement with this statement, showing that blood in the stool was the main symptom. There is no doubt that blood in the stool is a crucial symptom for the physician to suspect ulcerative colitis even if the clinician is not specialized in IBD.
CD patients presenting ileal disease frequently have systemic manifestations, and these results were confirmed in our study. Furthermore, CD patients with small intestine involvement usually present diarrhoea without urgency. In our study, urgency and faecal incontinence were frequent manifestations in colonic CD patients and in UC patients since urgency and possible faecal incontinence are symptoms related to cases of colonic and rectal involvement due to the loss of rectal distensibility (39) . We noticed that colonic Crohn's disease may present symptoms similar to those of UC. A new and important finding about location in the present study was that patients with isolated colonic involvement compared to other locations presented a higher frequency of alarming symptoms such as mucus and bloody diarrhoea, urgency, faecal incontinence, tenesmus, abdominal pain, weight loss, malnutrition, anaemia, and fever. This high frequency of alarming clinical manifestations may be the reason for a shorter time to diagnosis of colonic CD than found with other disease locations.
The left-sided colitis patients reported more diarrhoea with blood and mucus in the stool, faecal urgency and abdominal pain than proctitis patients, which may explain the earlier diagnosis of left-sided colitis patients. On the other hand, patients with proctitis presented a lower frequency of manifestations, which may contribute to a delay in the diagnosis of these patients compared to patients with other UC locations.
Patients diagnosed before the age of 16 years presented the highest frequency of most symptoms. Otherwise, patients over 40 years of age generally had a lower frequency of symptoms, similar to the findings of the studies of Charpentier and Conley (29, 32) . Clinical manifestations were mild in older patients compared with those in younger patients as described by Butter (43) . This difference is possibly due to a less active immune system. On the other hand, the high frequency of insomnia may be a typical symptom of patients with advancing age.
In the onset of the clinical manifestations of UC, the presence of intestinal symptoms was described more frequently by UC patients than by CD patients. Otherwise, CD patients usually presented with more pronounced systemic symptoms. This characteristic of CD contributes to a delayed diagnosis, especially when the patient seeks care with a team not familiar with IBD.
Finally, our sample included patients who typically had an established diagnosis of IBD at follow-up. Memory biases may have occurred. In the future, prospective studies involving incidental cases may lead to clearer characterization of the onset of clinical manifestations of IBD in patients.
CONCLUSION
Ulcerative colitis presented a high frequency of intestinal symptoms, and Crohn's disease showed a high frequency of systemic manifestations. There was a long delay in diagnosis, but individuals with disease in more extensive locations and more pronounced symptoms showed a shorter delay in diagnosis. The characterization of the onset of symptoms is critical so that health professionals can suspect IBD from the onset of the disease, contributing to an earlier diagnosis.
